The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study

The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury. Statins, prescribed for lipid reduction, have anti-inflammatory, anti-thrombotic, and immunomodulatory properties and are associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Umakanthan, Srikanth, Senthil, Sanjum, John, Stanley, Madhavan, Mahesh K., Das, Jessica, Patil, Sonal, Rameshwaram, Raghunath, Cintham, Ananya, Subramaniam, Venkatesh, Yogi, Madhusudan, Bansal, Abhishek, Achutham, Sumesh, Shekar, Chandini, Murthy, Vijay, Selvaraj, Robbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294274/
https://www.ncbi.nlm.nih.gov/pubmed/35865966
http://dx.doi.org/10.3389/fphar.2022.742273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294274/
https://www.ncbi.nlm.nih.gov/pubmed/35865966
http://dx.doi.org/10.3389/fphar.2022.742273

Ejemplares similares